Efficacy and safety of geptanolimab (GB226) for relapsed or refractory peripheral T cell lymphoma: an open-label phase 2 study (Gxplore-002)Yuankai Shi, Qian Wang, Jianqiu Wu et al.|Journal of Hematology & Oncology|2021Cited by 64
(−)-Epigallocatechin gallate (EGCG)-nanoethosomes as a transdermal delivery system for docetaxel to treat implanted human melanoma cell tumors in miceQizhen Du, Nagaiya Ravichandran, Yong‐Quan Xu et al.|International Journal of Pharmaceutics|2016Cited by 44
Meta-analysis of 49 549 individuals imputed with the 1000 Genomes Project reveals an exonic damaging variant in <i>ANGPTL4</i> determining fasting TG levelsAniko Sabo, Jennifer E. Huffman, Ani Manichaikul et al.|Journal of Medical Genetics|2016Cited by 38
Comparison of efficacy and safety of ripertamab (SCT400) versus rituximab (Mabthera <sup>®</sup> ) in combination with CHOP in patients with previously untreated CD20‐positive diffuse large B‐cell lymphoma: A randomized, single‐blind, phase III clinical trialYuankai Shi, Yanan Ji, Qingyuan Zhang et al.|Hematological Oncology|2022Cited by 9